Home Infusion Therapy Market is expected to reach US$ 64.56 Billion by 2030, powered by rising chronic diseases, increased insurance coverage and demand for cost-effective, personalized healthcare in a value-based care setting
13 Oct, 2023

In a report titled "Home Infusion Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2030," published recently by Renub Research, market share insights are included along with a thorough industry analysis. The report also includes research on regions, competitors, and the recent expansion of the Home Infusion Therapy Market.

A CAGR of 6.10% is predicted for the Home Infusion Therapy Market between 2022 and 2030. The global surge in chronic diseases, encompassing prevalent conditions like cancer, heart disease, and diabetes, profoundly influences the home infusion therapy market. As chronic diseases become increasingly widespread worldwide, necessitating long-term treatment, home infusion therapy emerges as a more effective and efficient option for administration. Home infusion therapy, the provision of medications and cures in a patient's home, offers a convenient and cost-effective approach to managing various conditions, aligning with the World Health Organization's finding that chronic diseases contribute to 74% of global deaths, a figure projected to rise to 75% by 2025.

Furthermore, the aging global population contributes to increased chronic diseases, especially in older adults needing long-term care. Home infusion therapy is a convenient and cost-effective solution for this demographic, aligning with the rising demand for personalized healthcare. The growing emphasis on preventive care globally boosts demand for home infusion, especially for administering preventive medications at home. Also, the global shift to a value-based care model makes home infusion an attractive and cost-effective option for healthcare providers, aligning with evolving healthcare delivery approaches.

Likewise, the global market for home infusion therapy is thriving due to sophisticated technologies enabling a variety of at-home treatments and increased insurance coverage. These innovations increase the viability of home infusion by allowing the delivery of various medications at home. Wearable devices and telemedicine aid in remote patient monitoring, particularly beneficial for those in rural areas or with travel challenges. Enhanced affordability is driven by expanded insurance coverage, including dedicated programs; ensuring patients receive essential care without financial barriers. This highlights the synergy between technological advancements and insurance expansion in shaping the global home infusion therapy market.

Infusion pumps sustain high growth in the home infusion therapy market due to their pivotal role in delivering medications and fluids safely and efficiently in a home setting

The increasing preference for home-based care, driven by patient comfort and cost-effectiveness, elevates the demand for infusion pumps. Technological advancements, such as portable and user-friendly designs, enhance their appeal. With a rising aging population and a growing range of treatable conditions through home infusion, infusion pumps remain indispensable, contributing to their continued prominence and growth in the market.

Report Details:

As more patients opt for home-based care, the demand for parenteral nutrient infusion rises

Parenteral nutrients emerge as a standout sector in the home infusion therapy market due to their vital role in providing essential nutrients intravenously. This sector's significance lies in addressing nutritional deficiencies and supporting patients with various conditions, contributing to the overall growth of home infusion therapy. The convenience, flexibility, and personalized nature of parenteral nutrient infusions make them a key driver in the expanding landscape of home-based healthcare.

United States home infusion market is a dynamic and fast-expanding sector

The increasing prevalence of chronic diseases prompts a preference for home-based care, particularly among the aging population. Technological advances broaden the scope of therapies administered at home, while expanded insurance coverage enhances financial accessibility. Home infusion's appeal is patient convenience, offering a time-saving, cost-effective alternative. Furthermore, trends like the demand for personalized care, emphasis on preventive healthcare, and the healthcare system's shift to a value-based model contribute to home infusion's status as a cost-effective and patient-centric solution.

Competitive Landscape

Pfizer Inc., Smith & Nephew P.C., Terumo Corporation, Johnson & Johnson Services, Inc., Becton, Dickinson and Company, Baxter International Inc., ICU Medical, and Eli Lilly and Company are the leading companies operating in the global home infusion therapy market.

Market Summary

• Product - The report analyses the Global Home Infusion Therapy Market by-product from 4 angles (Infusion Pumps, Intravenous Sets, IV Cannulas, and Needleless Connectors).
• Application - A Renub Research report on the Global Home Infusion Therapy Market looks at the application from 7 angles (Anti-Infective, Hydration Therapy, Chemotherapy, Internal Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, and Others).
• Countries - There are 26 different perspectives on the Global Home Infusion Therapy Market by countries (United States, Canada, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE and Rest of World).
• Key Players - Every significant player in the Global Home Infusion Therapy Market has been discussed from 3 perspectives (Overview, Recent Developments, and Revenue): Pfizer Inc., Smith & Nephew P.C, Terumo Corporation, Johnson & Johnson Services, Inc., Becton, Dickinson and Company, Baxter International Inc., ICU Medical and Eli Lilly and Company.

About Us

Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us
Renub Research
Phone: +1-478-202-3244 (USA) | +91-120-421-9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research